191 related articles for article (PubMed ID: 21206975)
1. Circulating melanoma cells and survival in metastatic melanoma.
Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
[TBL] [Abstract][Full Text] [Related]
2. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
[TBL] [Abstract][Full Text] [Related]
4. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
[TBL] [Abstract][Full Text] [Related]
6. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
[TBL] [Abstract][Full Text] [Related]
7. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
[TBL] [Abstract][Full Text] [Related]
9. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.
Väisänen A; Kallioinen M; Taskinen PJ; Turpeenniemi-Hujanen T
J Pathol; 1998 Sep; 186(1):51-8. PubMed ID: 9875140
[TBL] [Abstract][Full Text] [Related]
12. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
Haanen JB; Baars A; Gomez R; Weder P; Smits M; de Gruijl TD; von Blomberg BM; Bloemena E; Scheper RJ; van Ham SM; Pinedo HM; van den Eertwegh AJ
Cancer Immunol Immunother; 2006 Apr; 55(4):451-8. PubMed ID: 16034562
[TBL] [Abstract][Full Text] [Related]
13. Investigation of female survival benefit in metastatic melanoma.
Richardson B; Price A; Wagner M; Williams V; Lorigan P; Browne S; Miller JG; Mac Neil S
Br J Cancer; 1999 Aug; 80(12):2025-33. PubMed ID: 10471056
[TBL] [Abstract][Full Text] [Related]
14. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker.
Kanemaru H; Fukushima S; Yamashita J; Honda N; Oyama R; Kakimoto A; Masuguchi S; Ishihara T; Inoue Y; Jinnin M; Ihn H
J Dermatol Sci; 2011 Mar; 61(3):187-93. PubMed ID: 21273047
[TBL] [Abstract][Full Text] [Related]
15. Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.
Samija I; Lukac J; Marić-Brozić J; Kusić Z
Croat Med J; 2004 Apr; 45(2):142-8. PubMed ID: 15103749
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma.
Helfrich I; Edler L; Sucker A; Thomas M; Christian S; Schadendorf D; Augustin HG
Clin Cancer Res; 2009 Feb; 15(4):1384-92. PubMed ID: 19228739
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
20. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]